Thank you for your message about B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme. You must verify your email address to receive further communication about this trial. Please check your email for a verification message.
Didn't receive an email verification message? You can wait a few minutes or submit another form.Submit another form
We were not able to send your contact info at this time.
Clinical Trial Study Email Verified B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma MultiformeContinue to explore Clinical Trials